Human Recombinant EPO, STEMCELL Technologies (CAT#: STEM-CT-0852-ZJF)

Erythropoietin (EPO) is a glycoprotein growth factor that is produced primarily in the kidney in response to hypoxia or anemia. It is the principal physiological regulator of erythropoiesis. EPO promotes erythropoiesis by binding to a homodimeric cell surface receptor that activates JAK2/STAT5, PI3K/AKT, and MAPK pathways, and stimulates the proliferation and differentiation of erythroid progenitor cells (Jelkmann; Kuhrt & Wojchowski).

Subtype: Cytokines
Cell Type: Hematopoietic Stem and Progenitor Cells, Mesoderm, PSC-Derived, Pluripotent Stem Cells
Species: Human
Area of Interest: Stem Cell Biology
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant EGF, ACF, STEMCELL Technologies
Human Recombinant EGFR, STEMCELL Technologies
Human Recombinant FGF-4, STEMCELL Technologies
Human Recombinant FGF-5, STEMCELL Technologies